Home Cart 0 Sign in  
X

[ CAS No. 1443-80-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1443-80-7
Chemical Structure| 1443-80-7
Chemical Structure| 1443-80-7
Structure of 1443-80-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1443-80-7 ]

Related Doc. of [ 1443-80-7 ]

Alternatived Products of [ 1443-80-7 ]

Product Details of [ 1443-80-7 ]

CAS No. :1443-80-7 MDL No. :MFCD00001825
Formula : C9H7NO Boiling Point : -
Linear Structure Formula :- InChI Key :NLPHXWGWBKZSJC-UHFFFAOYSA-N
M.W : 145.16 Pubchem ID :74044
Synonyms :

Calculated chemistry of [ 1443-80-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.11
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 41.35
TPSA : 40.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.56
Log Po/w (XLOGP3) : 1.22
Log Po/w (WLOGP) : 1.76
Log Po/w (MLOGP) : 1.08
Log Po/w (SILICOS-IT) : 2.14
Consensus Log Po/w : 1.55

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.85
Solubility : 2.07 mg/ml ; 0.0142 mol/l
Class : Very soluble
Log S (Ali) : -1.68
Solubility : 3.07 mg/ml ; 0.0211 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.8
Solubility : 0.232 mg/ml ; 0.0016 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.21

Safety of [ 1443-80-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1443-80-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1443-80-7 ]
  • Downstream synthetic route of [ 1443-80-7 ]

[ 1443-80-7 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 1443-80-7 ]
  • [ 20099-89-2 ]
YieldReaction ConditionsOperation in experiment
61% With N-Bromosuccinimide In ethyl acetate at 40℃; In a 100 mL round bottom flask, 10 mmol of 4-cyanoacetophenone and 11 mmol of N-bromosuccinimide (NBS) were added.35mL of ethyl acetate dissolved,Then add 1g of Amberlyst 15 ion exchange resin as catalyst.The reaction was warmed to 40°C and reacted. After TLC tracks the reaction,The reaction solution was filtered to remove Amberlyst 15 ion exchange resin,The filtrate was spin-dried and separated by column chromatography (eluent: petroleum ether/ethyl acetate) to give a white solid with a yield of 61percent.
61% With N-Bromosuccinimide In ethyl acetate at 40℃; In a 100 mL round bottom flask, 10 mmol of 4-cyanoacetophenone and 11 mmol of N-bromosuccinimide (NBS) were added.35mL of ethyl acetate dissolved,Then add 1g of Amberlyst 15 ion exchange resin as catalyst.The reaction was warmed to 40°C and reacted. After TLC tracks the reaction,The reaction solution was filtered to remove Amberlyst 15 ion exchange resin, and the filtrate was spin-dried.Column chromatography (eluent: petroleum ether/ethyl acetate) afforded a white solid in 61percent yield.
38% With Oxone; ammonium bromide In methanol at 20℃; for 48 h; General procedure: Oxone (1.352 g, 2.2 mmol) was added to the well stirred solution of substrate (2 mmol) and NH4Br (0.215 g, 2.2 mmol) in methanol (10 ml) and the reaction mixture was allowed to stir at room temperature (or reflux temperature). After completion of the reaction, as monitored by TLC, the reaction mixture was quenched with aqueous sodium thiosulfate, and extracted with ethyl acetate (3.x.25 ml). Finally, the combined organic layer was washed with water, dried over anhydrous sodium sulfate, filtered and removal of solvent in vacuo yielded a crude residue, which was further purified by column chromatography over silica gel (finer than 200 mesh) to afford pure products. All the products were identified on the basis of 1H NMR and mass spectral data.
29% With hydrogen bromide; bromine In chloroform j)
Preparation of 2-Bromo-4'-cyanoacetophenone
To a mixture of para-cyanoacetophenone (52 g, 0.36 mol) in chloroform (520 ml) and 48percent HBr (5.2 ml), a solution of bromine (19.3 ml) in chloroform (52 ml) was added dropwise over a period of 20 min.
The mixture was stirred for 3 h at room temperature and neutralized to pH7 with sat. NaHCO3.
The organic layer was washed with sat.
NaCl and dried over anhydrous Na2SO4 and concentrated.
The residue was chromatographed on silica gel (AcOEt/n-hexane=1/3 as an eluent) and recrystallized to obtain 2-bromo-4'-cyanoacetophenone as a colourless plate (23.4 g, 29percent).
EI-MS(+): m/z 223 (M+)
1H-NMR(CDCl3): 4.43(2H,s), 7.80(2H,d,J=6.6 Hz), 8.09(2H,d,J=6.6 Hz)
29% With hydrogen bromide; bromine In chloroform g)
Preparation of 2-bromo-4'-cyanoacetophenone
To a mixture of para-cyanoacetophenone (52 g, 0.36 mol) in chloroform (520 ml) and 48percent HBr (5.2 ml), a solution of bromine (19.3 ml) in chloroform (52 ml) was added dropwise over a period of 20 min.
The mixture was stirred for 3 h at room temperature and neutralized to pH7 with sat. NaHCO3.
The organic layer was washed with sat.
NaCl and dried over anhydrous Na2SO4 and concentrated.
The residue was chromatographed on silica gel (AcOEt/n-hexane=1/3 as an eluent) and recrystallized to obtain 2-bromo-4'-cyanoacetophenone as a colourless plate (23.4 g, 29percent).
EI-MS(+): m/z 223 (M+)
1H-NMR(CDCl3) δ4.43(2H,s), 7.80(2H,d,J=6.6 Hz), 8.09(2H,d,J=6.6 Hz)

Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1980, vol. 313, # 4, p. 315 - 323
[2] European Journal of Organic Chemistry, 2017, vol. 2017, # 43, p. 6390 - 6400
[3] Helvetica Chimica Acta, 2013, vol. 96, # 5, p. 889 - 896
[4] Chemical and Pharmaceutical Bulletin, 1998, vol. 46, # 4, p. 623 - 630
[5] Patent: CN107629023, 2018, A, . Location in patent: Paragraph 0135; 0138; 0139; 0140
[6] Patent: CN107629022, 2018, A, . Location in patent: Paragraph 0212; 0213; 0214; 0215
[7] RSC Advances, 2016, vol. 6, # 42, p. 35602 - 35608
[8] Tetrahedron Letters, 2012, vol. 53, # 2, p. 191 - 195
[9] Patent: US6300353, 2001, B1,
[10] Patent: US6300353, 2001, B1,
[11] Patent: US2784194, 1954, ,
[12] Yakugaku Zasshi, 1952, vol. 72, p. 305,307[13] Chem.Abstr., 1953, p. 2133
[14] Journal of Medicinal Chemistry, 1971, vol. 14, # 10, p. 977 - 982
[15] Journal of Medicinal Chemistry, 1987, vol. 30, # 8, p. 1497 - 1502
[16] Journal of Organic Chemistry USSR (English Translation), 1992, vol. 28, # 7, p. 1162 - 1168[17] Zhurnal Organicheskoi Khimii, 1992, vol. 28, # 7, p. 1472 - 1478
[18] Journal of Physical Chemistry, 1995, vol. 99, # 20, p. 8190 - 8195
[19] Patent: WO2004/85408, 2004, A1, . Location in patent: Page 285
[20] Patent: US5935776, 1999, A,
[21] Patent: US5648372, 1997, A,
[22] Patent: US4812470, 1989, A,
[23] Patent: EP1231210, 2002, A2, . Location in patent: Page 73
[24] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 14, p. 5063 - 5070
[25] European Journal of Medicinal Chemistry, 2012, vol. 57, p. 407 - 416
[26] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 7, p. 2031 - 2034
[27] Advanced Synthesis and Catalysis, 2013, vol. 355, # 18, p. 3570 - 3574
[28] Chemical Communications, 2014, vol. 50, # 51, p. 6726 - 6728
[29] Organic Letters, 2017, vol. 19, # 8, p. 1994 - 1997
[30] Letters in Drug Design and Discovery, 2017, vol. 14, # 5, p. 528 - 539
[31] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 16, p. 3726 - 3732
[32] Organic and Biomolecular Chemistry, 2017, vol. 15, # 38, p. 8134 - 8139
[33] Advanced Synthesis and Catalysis, 2018, vol. 360, # 8, p. 1628 - 1633
[34] Tetrahedron Letters, 2018, vol. 59, # 33, p. 3214 - 3219
[35] Chemical Communications (Cambridge, United Kingdom), 2018, vol. 54, # 86, p. 12182 - 12185
  • 2
  • [ 1443-80-7 ]
  • [ 20099-89-2 ]
  • [ 21661-87-0 ]
YieldReaction ConditionsOperation in experiment
45% With N-Bromosuccinimide; silica gel In methanol for 0.3 h; Reflux General procedure: The α-bromination reaction was carried out using acetophenone (1200 mg, 10 mmol), N-bromosuccinimide (2136 mg, 12 mmol), 10percent (w/w) silica gel (120mg) in 10 mL of methanol at reflux conditions until the disappearance of the substrate. (Note: 2136mg of N-bromosuccinimide was added portion wise i.e. 356 mg for each time in six portions). The progress of the reaction was monitored by TLC. The reaction mass was filtered after the completion of the reaction as per TLC and the catalyst was collected for reuse. The filtrate was concentrated under vacuum. Double distilled water was added to the reaction mixture and quenched with aqueous sodium thiosulfate and the product extracted with dichloromethane (Caution: Severe burning sensation of eyes was observed during the work-up process). The layers were separated and the organic layer was collected and washed thrice with distilled water (3×50mL). The collected organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The obtained crude product was purified by column chromatography over silica gel (60–120 mesh) using n-hexane–EtOAc (99:1 ratio). With the aim of studying the recycling of the catalyst, the isolated catalyst was washed with ethyl acetate (5mL) after its filtration from the reaction medium, collected and dried in vacuum at 70°C to a constant weight. Subsequently it was reused for the α-bromination of acetophenone and achieved 95percent, 86percent and 83percent yields of product (2a) for first, second and third reuse of catalyst respectively. All products gave spectroscopic data in agreement with the literature [15,21,27–30]. The method is also very practical for scale up in process development. We attempted large scale (100 gram scale) synthesis of 2-bromo-1-phenylethanone 2a and obtained fruitful results with isolated yields ranging from 93percent to 96percent.
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 12, p. 4042 - 4056
[2] Chinese Chemical Letters, 2014, vol. 25, # 1, p. 179 - 182
  • 3
  • [ 67-56-1 ]
  • [ 1443-80-7 ]
  • [ 20099-89-2 ]
  • [ 164594-65-4 ]
YieldReaction ConditionsOperation in experiment
35% for 16 h; Reflux General procedure: Oxone (1.352 g, 2.2 mmol) was added to the well stirred solution of substrate (2 mmol) and NH4Br (0.215 g, 2.2 mmol) in methanol (10 ml) and the reaction mixture was allowed to stir at room temperature (or reflux temperature). After completion of the reaction, as monitored by TLC, the reaction mixture was quenched with aqueous sodium thiosulfate, and extracted with ethyl acetate (3.x.25 ml). Finally, the combined organic layer was washed with water, dried over anhydrous sodium sulfate, filtered and removal of solvent in vacuo yielded a crude residue, which was further purified by column chromatography over silica gel (finer than 200 mesh) to afford pure products. All the products were identified on the basis of 1H NMR and mass spectral data.
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 2, p. 191 - 195
  • 4
  • [ 25309-65-3 ]
  • [ 1443-80-7 ]
  • [ 20099-89-2 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 4, p. 784 - 787
  • 5
  • [ 1443-80-7 ]
  • [ 65695-05-8 ]
Reference: [1] Patent: US2003/45546, 2003, A1,
  • 6
  • [ 623-00-7 ]
  • [ 108-24-7 ]
  • [ 1591-30-6 ]
  • [ 1443-80-7 ]
  • [ 32446-66-5 ]
  • [ 100-47-0 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 3, p. 936 - 942
  • 7
  • [ 1443-80-7 ]
  • [ 28357-95-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1979, vol. 27, # 11, p. 2735 - 2742
  • 8
  • [ 1443-80-7 ]
  • [ 20099-90-5 ]
Reference: [1] Chemische Berichte, 1934, vol. 67, p. 1209
  • 9
  • [ 1443-80-7 ]
  • [ 552846-23-8 ]
YieldReaction ConditionsOperation in experiment
93% at 120℃; for 24 h; General procedure: A mixture of the required nitrile (1 mmol), sodium azide(1 mmol) and the catalyst MNP (0.05 g) was stirred at 120° C in PEG (1 mL) as solvent. After completion of the reaction, as indicated by TLC, the mixture was cooled to room temperature and diluted with 1:1 H2O:Ethyl acetate(10 mL) and then stirred at ambient temperature (10 min). The catalyst was removed by applying a magnetic field, and the decantate was treated with HCl (4 N, 10 mL). The organic layer was separated, washed with water, dried over sodium sulfate and concentrated to precipitate the crude crystalline solid. The pure tetrazoles were characterized bytheir spectroscopic data and melting points.
93% With sodium azide; C19H17N3O4(2-)*Cu(2+) In ethylene glycol at 120℃; for 3 h; General procedure: In 25mL round-bottomed flask, sodium azide (0.076g, 1.2mmol) and polymeric copper (II) complex (0.005g) were added to a solution of benzonitrile (0.103g, 1mmol) in ethylene glycol (3mL) with stirring at room temperature. The reaction temperature was raised up to 120°C for 3h. The reaction was monitored by TLC at regular intervals. After completion of the reaction, the reaction mixture was cooled to room temperature and treated with 10mL HCl (2N) and extracted with 10mL ethyl acetate. The resulted organic layers were separated and washed with 2×10mL distilled water, dried over anhydrous sodium sulphate and evaporated under reduced pressure. The residue was then purified by column chromatography on silica gel (100–200 mesh) to afford the corresponding products.
91% at 120℃; for 30 h; Green chemistry General procedure: In a round-bottomed flask, a mixture of nitrile (1 mmol) and sodium azide (1.2 mmol) in the presence of 40 mg of Fe3O4*SBTU*Ni(II) was stirred at 120 °C in PEG for an appropriate time (monitored by TLC). Then, the reaction mixture was cooled down to room temperature. After magnetic separation of catalyst, HCl (4 N, 10 mL) was added to the filtrate and the product extracted with ethyl acetate (2 × 10 mL). The organic layer was washed with water several times, dried with anhydrous Na2SO4 and concentrated to give the crude solid crystalline product.
90% With sodium azide; tetra(n-butyl)ammonium hydrogensulfate In water at 85℃; for 5 h; Green chemistry General procedure: General Procedure for Preparation of Tetrazoles in Water(Method II). TBAHS (0.25 mmol) was added to a mixture of nitrile (1 mmol), sodium azide (1.5 mmol), and 2 mL H2O in around-bottomed flask. The reaction mixture was heated to 85 °C. After completion of the reaction (as monitored by TLC), the crude reaction mixture was transferred into a separatory funnel, to which was added 1 N HCl (15 mL) extracted by ethylacetate (EtOAc, 10 mL × 5). The combined organic layers were washed with H2O and dried over anhydrous sodium sulfate, and were evaporated under reduced pressure to give pure 5-substituted-1H-tetrazole.
87% With sodium azide; activated Fuller’s earth In dimethyl sulfoxide at 120℃; for 3 h; Green chemistry General procedure: To a DMSO (3 ml) solution of nitrile (1 mmol), and sodium azide (1.5 mmol), was added catalyst (10 wt percent). The reaction mixture was stirred to 120 0C in an oil bath. The reaction was monitored by TLC. After completion of the reaction, the mixture was filtered to separate the catalyst. The filtrate was quenched with water (30 ml), acidified with 5N HCl (20 ml) to precipitate the product, extracted with ethyl acetate (2 X 20 ml). The combined organic layers were washed with water, dried over sodium sulphate and evaporated under reduced pressure to give the product.
78% at 120℃; for 10 h; General procedure: To a stirred mixture of sodium azide (1.2 mmol) in PEG-400(2 mL), a nitrile compound (1 mmol) and NiNP-PNF (200 mL) were added and heated at 120°C under atmospheric conditions.The reaction progress was monitored by TLC. Upon reaction completion, the mixture was allowed to cool to ambient temperature and then filtered and extracted with ethyl acetate. The organic layer was washed with 1N HCl, dried with anhydrous Na2SO4, and filtered to afford pure 5-substituted tetrazoles.
57% With indium(III) chloride; sodium azide In water; isopropyl alcohol at 160℃; Microwave irradiation General procedure: Synthesis of 4-acetylbenzotetrazole (2c). 4-Acetylbenzonitrile 3c (290 mg, 2 mmol), NaN3 (260 mg, 4 mmol), InCl3(89 mg, 0.4 mmol), and 8 mL of a 3:1 isopropanol/water mixture were added to a 30-mL Pyrex microwave vessel and capped. The microwave vessel was then placed in a Milestone Start Synth microwave reactor. The reaction was magnetically stirred and heated for 1 hour at 160 oC. The pressure in the vessels was not determined. The reaction was monitored by TLC using an ether/hexane mixture (typically50/50) for development. After cooling, the reaction mixture was diluted with saturated aqueous sodium bicarbonate (20mL) and washed with ethyl acetate (2 x 15 mL). The aqueous sodium bicarbonate layer was cooled to 0 oC and acidified to a pH of 2 or less with concentrated hydrochloric acid,which was added drop-wise. The precipitate formed was extracted with ethyl acetate (3 x 15 mL). The combined organic layers were dried over anhydrous sodium sulfate and decanted into a tared round bottom flask. The organic layer was concentrated under reduced pressure. The tetrazole product was recrystallized from ethyl acetate and hexane. All reagents mentioned above were used unpurified

Reference: [1] Applied Organometallic Chemistry, 2017, vol. 31, # 9,
[2] RSC Advances, 2016, vol. 6, # 79, p. 75227 - 75233
[3] Applied Organometallic Chemistry, 2018, vol. 32, # 8,
[4] New Journal of Chemistry, 2018, vol. 42, # 16, p. 13754 - 13762
[5] Journal of Organic Chemistry, 2004, vol. 69, # 8, p. 2896 - 2898
[6] RSC Advances, 2016, vol. 6, # 61, p. 56638 - 56646
[7] Transition Metal Chemistry, 2017, vol. 42, # 2, p. 131 - 136
[8] Journal of Organometallic Chemistry, 2018, vol. 870, p. 16 - 22
[9] Applied Organometallic Chemistry, 2016, vol. 30, # 8, p. 705 - 712
[10] Journal of Sulfur Chemistry, 2018, vol. 39, # 3, p. 237 - 251
[11] Applied Organometallic Chemistry, 2018, vol. 32, # 6,
[12] Bulletin of the Korean Chemical Society, 2015, vol. 36, # 1, p. 198 - 202
[13] Applied Organometallic Chemistry, 2017, vol. 31, # 7,
[14] Applied Organometallic Chemistry, 2017, vol. 31, # 12,
[15] Tetrahedron Letters, 2016, vol. 57, # 51, p. 5815 - 5819
[16] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 11, p. 3047 - 3054
[17] Australian Journal of Chemistry, 2017, vol. 70, # 10, p. 1127 - 1137
[18] European Journal of Organic Chemistry, 2008, # 23, p. 3928 - 3932
[19] RSC Advances, 2016, vol. 6, # 39, p. 32653 - 32660
[20] Medicinal Chemistry, 2017, vol. 13, # 4, p. 359 - 364
[21] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 2, p. 483 - 495
[22] Patent: WO2016/187521, 2016, A1, . Location in patent: Paragraph 0020; 0021
[23] Applied Organometallic Chemistry, 2017, vol. 31, # 5,
Same Skeleton Products
Historical Records